Early morbidity after aseptic revision hip arthroplasty in Denmark: a two-year nationwide study

M Lindberg-Larsen, C C Jørgensen, T B Hansen, S Solgaard, H Kehlet

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

    Resumé

    Data on early morbidity and complications after revision total hip replacement (THR) are limited. The aim of this nationwide study was to describe and quantify early morbidity after aseptic revision THR and relate the morbidity to the extent of the revision surgical procedure. We analysed all aseptic revision THRs from 1st October 2009 to 30th September 2011 using the Danish National Patient Registry, with additional information from the Danish Hip Arthroplasty Registry. There were 1553 procedures (1490 patients) performed in 40 centres and we divided them into total revisions, acetabular component revisions, femoral stem revisions and partial revisions. The mean age of the patients was 70.4 years (25 to 98) and the median hospital stay was five days (interquartile range 3 to 7). Within 90 days of surgery, the readmission rate was 18.3%, mortality rate 1.4%, re-operation rate 6.1%, dislocation rate 7.0% and infection rate 3.0%. There were no differences in these outcomes between high- and low-volume centres. Of all readmissions, 255 (63.9%) were due to 'surgical' complications versus 144 (36.1%) 'medical' complications. Importantly, we found no differences in early morbidity across the surgical subgroups, despite major differences in the extent and complexity of operations. However, dislocations and the resulting morbidity represent the major challenge for improvement in aseptic revision THR.

    OriginalsprogEngelsk
    TidsskriftThe Bone & Joint Journal
    Vol/bind96-B
    Udgave nummer11
    Sider (fra-til)1464-71
    Antal sider8
    ISSN2049-4394
    DOI
    StatusUdgivet - nov. 2014

    Fingeraftryk

    Denmark
    Hip
    Hip Replacement Arthroplasties
    Registries
    Ambulatory Surgical Procedures
    Reoperation
    Length of Stay

    Bibliografisk note

    ©2014 The British Editorial Society of Bone & Joint Surgery.

    Citer dette

    @article{40ec403845e04a86bdf979864e384df7,
    title = "Early morbidity after aseptic revision hip arthroplasty in Denmark: a two-year nationwide study",
    abstract = "Data on early morbidity and complications after revision total hip replacement (THR) are limited. The aim of this nationwide study was to describe and quantify early morbidity after aseptic revision THR and relate the morbidity to the extent of the revision surgical procedure. We analysed all aseptic revision THRs from 1st October 2009 to 30th September 2011 using the Danish National Patient Registry, with additional information from the Danish Hip Arthroplasty Registry. There were 1553 procedures (1490 patients) performed in 40 centres and we divided them into total revisions, acetabular component revisions, femoral stem revisions and partial revisions. The mean age of the patients was 70.4 years (25 to 98) and the median hospital stay was five days (interquartile range 3 to 7). Within 90 days of surgery, the readmission rate was 18.3{\%}, mortality rate 1.4{\%}, re-operation rate 6.1{\%}, dislocation rate 7.0{\%} and infection rate 3.0{\%}. There were no differences in these outcomes between high- and low-volume centres. Of all readmissions, 255 (63.9{\%}) were due to 'surgical' complications versus 144 (36.1{\%}) 'medical' complications. Importantly, we found no differences in early morbidity across the surgical subgroups, despite major differences in the extent and complexity of operations. However, dislocations and the resulting morbidity represent the major challenge for improvement in aseptic revision THR.",
    keywords = "Adult, Aged, Aged, 80 and over, Arthroplasty, Replacement, Hip/adverse effects, Denmark/epidemiology, Female, Follow-Up Studies, Hip Dislocation/epidemiology, Humans, Male, Middle Aged, Morbidity/trends, Osteoarthritis, Hip/surgery, Postoperative Complications/epidemiology, Prosthesis Failure, Reoperation, Retrospective Studies, Time Factors, Treatment Outcome",
    author = "M Lindberg-Larsen and J{\o}rgensen, {C C} and Hansen, {T B} and S Solgaard and H Kehlet",
    note = "{\circledC}2014 The British Editorial Society of Bone & Joint Surgery.",
    year = "2014",
    month = "11",
    doi = "10.1302/0301-620X.96B11.33949",
    language = "English",
    volume = "96-B",
    pages = "1464--71",
    journal = "Bone and Joint Journal",
    issn = "2049-4394",
    publisher = "British Editorial Society of Bone and Joint Surgery",
    number = "11",

    }

    Early morbidity after aseptic revision hip arthroplasty in Denmark : a two-year nationwide study. / Lindberg-Larsen, M; Jørgensen, C C; Hansen, T B; Solgaard, S; Kehlet, H.

    I: The Bone & Joint Journal, Bind 96-B, Nr. 11, 11.2014, s. 1464-71.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

    TY - JOUR

    T1 - Early morbidity after aseptic revision hip arthroplasty in Denmark

    T2 - a two-year nationwide study

    AU - Lindberg-Larsen, M

    AU - Jørgensen, C C

    AU - Hansen, T B

    AU - Solgaard, S

    AU - Kehlet, H

    N1 - ©2014 The British Editorial Society of Bone & Joint Surgery.

    PY - 2014/11

    Y1 - 2014/11

    N2 - Data on early morbidity and complications after revision total hip replacement (THR) are limited. The aim of this nationwide study was to describe and quantify early morbidity after aseptic revision THR and relate the morbidity to the extent of the revision surgical procedure. We analysed all aseptic revision THRs from 1st October 2009 to 30th September 2011 using the Danish National Patient Registry, with additional information from the Danish Hip Arthroplasty Registry. There were 1553 procedures (1490 patients) performed in 40 centres and we divided them into total revisions, acetabular component revisions, femoral stem revisions and partial revisions. The mean age of the patients was 70.4 years (25 to 98) and the median hospital stay was five days (interquartile range 3 to 7). Within 90 days of surgery, the readmission rate was 18.3%, mortality rate 1.4%, re-operation rate 6.1%, dislocation rate 7.0% and infection rate 3.0%. There were no differences in these outcomes between high- and low-volume centres. Of all readmissions, 255 (63.9%) were due to 'surgical' complications versus 144 (36.1%) 'medical' complications. Importantly, we found no differences in early morbidity across the surgical subgroups, despite major differences in the extent and complexity of operations. However, dislocations and the resulting morbidity represent the major challenge for improvement in aseptic revision THR.

    AB - Data on early morbidity and complications after revision total hip replacement (THR) are limited. The aim of this nationwide study was to describe and quantify early morbidity after aseptic revision THR and relate the morbidity to the extent of the revision surgical procedure. We analysed all aseptic revision THRs from 1st October 2009 to 30th September 2011 using the Danish National Patient Registry, with additional information from the Danish Hip Arthroplasty Registry. There were 1553 procedures (1490 patients) performed in 40 centres and we divided them into total revisions, acetabular component revisions, femoral stem revisions and partial revisions. The mean age of the patients was 70.4 years (25 to 98) and the median hospital stay was five days (interquartile range 3 to 7). Within 90 days of surgery, the readmission rate was 18.3%, mortality rate 1.4%, re-operation rate 6.1%, dislocation rate 7.0% and infection rate 3.0%. There were no differences in these outcomes between high- and low-volume centres. Of all readmissions, 255 (63.9%) were due to 'surgical' complications versus 144 (36.1%) 'medical' complications. Importantly, we found no differences in early morbidity across the surgical subgroups, despite major differences in the extent and complexity of operations. However, dislocations and the resulting morbidity represent the major challenge for improvement in aseptic revision THR.

    KW - Adult

    KW - Aged

    KW - Aged, 80 and over

    KW - Arthroplasty, Replacement, Hip/adverse effects

    KW - Denmark/epidemiology

    KW - Female

    KW - Follow-Up Studies

    KW - Hip Dislocation/epidemiology

    KW - Humans

    KW - Male

    KW - Middle Aged

    KW - Morbidity/trends

    KW - Osteoarthritis, Hip/surgery

    KW - Postoperative Complications/epidemiology

    KW - Prosthesis Failure

    KW - Reoperation

    KW - Retrospective Studies

    KW - Time Factors

    KW - Treatment Outcome

    U2 - 10.1302/0301-620X.96B11.33949

    DO - 10.1302/0301-620X.96B11.33949

    M3 - Journal article

    C2 - 25371458

    VL - 96-B

    SP - 1464

    EP - 1471

    JO - Bone and Joint Journal

    JF - Bone and Joint Journal

    SN - 2049-4394

    IS - 11

    ER -